On the other hand, the ratio of [proinsulin]/MMP activity was ~1:50 during the compensation phase, whereas in decompensated T2D this ratio was 1:12, suggesting that this ratio may become a diagnostic biomarker to assess diabetic decompensation [38]. Here, INS is linked to type 2 diabetes mellitus.